Audiologists in Sedona, AZ Accepting Medicare
5 Audiologists found. Showing 1 - 5
 Debbie L Kelley, AU D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 61 Bell Rock Plz, Ste B, Sedona, AZ 86351 Phone: 928-284-2116 Fax: 928-496-2122 |
 Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 100 Verde Valley School Rd Ste 105, Sedona, AZ 86351 Phone: 928-284-5200 Fax: 928-284-5201 |
Dr. Megan Brooking Booth, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 6446 State Route 179 Ste 209, Sedona, AZ 86351 Phone: 928-284-2116 |
The Hearing Professionals, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 61 Bell Rock Plz, Suite B, Sedona, AZ 86351 Phone: 928-284-5200 Fax: 928-222-0008 |
Dr. Carol M Servin, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 70 Rim Shadows Cir, Sedona, AZ 86336 Phone: 928-274-2495 |
News Archive
UCLA School of Dentistry awarded NIH grant to study methamphetamine's oral, dental health consequences
The abuse of methamphetamine - a powerful and highly addictive psychostimulant that is toxic to the nervous system - has reached epidemic proportions in many parts of the United States. The National Institute on Drug Abuse estimates that more than 10 million Americans have tried methamphetamine, while more than 1.4 million are habitual users.
Avastin helps those with radiation retinopathy
Patients with radiation retinopathy who were destined to go blind within five years now can keep their sight longer through localized treatment with Avastin, a well-known cancer drug, according to a two-year study published in the June, 2007 Archives of Ophthalmology.
Mental health problems are common among smokers and adults with substance use disorders, study finds
Mental health problems are common among adults who smoke cigarettes and those with substance use disorders, illustrating a need for treating smoking and mental health problems together, according to a new study by Indiana University.
Sarepta Therapeutics reports positive safety results from AVI-7288 Phase I study
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced positive safety results from a Phase I multiple ascending dose study of AVI-7288 in healthy volunteers.
› Verified 4 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Speech-Language Pathologists
Audiologists
Podiatrists